These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 25271250

  • 1. Long-term effects of adrenalectomy or spironolactone on blood pressure control and regression of left ventricle hypertrophy in patients with primary aldosteronism.
    Indra T, Holaj R, Štrauch B, Rosa J, Petrák O, Šomlóová Z, Widimský J.
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1109-17. PubMed ID: 25271250
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Predictive factors of left ventricular mass changes after treatment of primary aldosteronism.
    Catena C, Colussi GL, Marzano L, Sechi LA.
    Horm Metab Res; 2012 Mar; 44(3):188-93. PubMed ID: 22351477
    [Abstract] [Full Text] [Related]

  • 4. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism.
    Rossi GP, Cesari M, Cuspidi C, Maiolino G, Cicala MV, Bisogni V, Mantero F, Pessina AC.
    Hypertension; 2013 Jul; 62(1):62-9. PubMed ID: 23648698
    [Abstract] [Full Text] [Related]

  • 5. Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone.
    Ori Y, Chagnac A, Korzets A, Zingerman B, Herman-Edelstein M, Bergman M, Gafter U, Salman H.
    Nephrol Dial Transplant; 2013 Jul; 28(7):1787-93. PubMed ID: 23378418
    [Abstract] [Full Text] [Related]

  • 6. Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score-Matching Follow-Up Study With Tissue Doppler Imaging.
    Chang YY, Liao CW, Tsai CH, Chen CW, Pan CT, Chen ZW, Chen YL, Lin LC, Chang YR, Wu VC, Wu KD, Hung CS, Lin YH, TAIPAI Study Group* †, TAIPAI Study Group*<xref ref-type="author-note" rid="jah34587-note-0001"><sup>†</sup></xref>.
    J Am Heart Assoc; 2019 Nov 19; 8(22):e013263. PubMed ID: 31718437
    [Abstract] [Full Text] [Related]

  • 7. Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness.
    Holaj R, Rosa J, Zelinka T, Štrauch B, Petrák O, Indra T, Šomlóová Z, Michalský D, Novák K, Wichterle D, Widimský J.
    J Hypertens; 2015 Apr 19; 33(4):874-82; discussion 882. PubMed ID: 25490707
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Factors influencing left ventricular mass regression in patients with primary aldosteronism post adrenalectomy.
    Lin YH, Huang KH, Lee JK, Wang SM, Yen RF, Wu VC, Chung SD, Liu KL, Chueh SC, Lin LY, Ho YL, Chen MF, Wu KD, TAIPAI study group.
    J Renin Angiotensin Aldosterone Syst; 2011 Mar 19; 12(1):48-53. PubMed ID: 20719880
    [Abstract] [Full Text] [Related]

  • 13. Long-term results of surgical and conservative treatment of patients with primary aldosteronism.
    Horký K, Widimský J, Hradec E, Gregorová I, Hradec M.
    Exp Clin Endocrinol; 1987 Dec 19; 90(3):337-46. PubMed ID: 3450533
    [Abstract] [Full Text] [Related]

  • 14. [Left ventricular myocardial structure and function in patients with primary aldosteronism].
    Arabidze GG, Chikhladze NM, Sergakova LM, Iarovaia EB.
    Ter Arkh; 1999 Dec 19; 71(9):13-9. PubMed ID: 10553618
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ventricular repolarization before and after treatment in patients with secondary hypertension due to renal-artery stenosis and primary aldosteronism.
    Maule S, Bertello C, Rabbia F, Milan A, Mulatero P, Milazzo V, Papotti G, Veglio F.
    Hypertens Res; 2011 Oct 19; 34(10):1078-81. PubMed ID: 21677661
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
    Paulis L, Matuskova J, Adamcova M, Pelouch V, Simko J, Krajcirovicova K, Potacova A, Hulin I, Janega P, Pechanova O, Simko F.
    Acta Physiol (Oxf); 2008 Sep 19; 194(1):45-55. PubMed ID: 18419778
    [Abstract] [Full Text] [Related]

  • 20. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E, Sani C, Perazzoli F, Casoli MC, Negro A, Dotti C.
    Am J Hypertens; 1995 Sep 19; 8(9):884-93. PubMed ID: 8541003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.